Robert Francomano

Robert is a highly experienced Chief Commercial Officer, most recently with SELLAS Life Sciences Group, Inc., where he has focused on on developing the immuno-oncology operational and strategic commercial readiness ahead of the organizations first-ever product launch. Prior to joining SELLAS, Mr. Francomano served as Chief Commercial Officer at Stemline Therapeutics, where he led the transformation of that organization from a clinical-stage entity to a company with full commercial capabilities and infrastructure in both the United States and European Union. Before that, Mr. Francomano held several key roles of increasing responsibility within the oncology divisions at Pfizer, GlaxoSmithKline and AstraZeneca, with vast responsibilities that spanned the developmental continuum from asset discovery through patent expiry. Mr. Francomano received his Masters of Business Administration in Management/Pharmaceutical Studies from the University of Albany and his Bachelor of Science, Business in Marketing/Management at Siena College.